Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Nocera, INERGX form 50/50 energy joint venture targeting INERGX valuation of $250 million

Nocera, INERGX form 50/50 energy joint venture targeting INERGX valuation of $250 million

ReutersReuters2026/08/11 12:05
  • Nocera entered a binding term sheet with INERGX to form a 50/50 joint venture, Nocera-INERGX Energy Ventures, focused on mission-critical energy assets.
  • Vehicle targets acquisitions across battery storage, power electronics, AI-enabled energy management, renewable energy, and direct infrastructure ownership for AI data centers, defense, heavy industry.
  • Parties set an objective to build INERGX toward a USD 250 million valuation; Nocera ascribed a minimum USD 65 million valuation in its earlier equity investment.
  • INERGX is expected to manage day-to-day assets; Nocera is expected to handle corporate administration, subject to a definitive agreement within 90 days.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nocera Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608110800PRIMZONEFULLFEED9807393) on August 11, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)

A $2.4 billions debt financing round, led by funds under Blue Owl Capital Inc., has been finalized. The funds will be allocated to cloud service provider IREN Ltd. to purchase NVIDIA's Blackwell Ultra GPUs, supporting the development of its data center campus in Canada.

智通财经2026/08/29 02:27
Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)